Acetylcholine Release Inhibitors
"Acetylcholine Release Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds that block release of the neurotransmitter ACETYLCHOLINE.
| Descriptor ID |
D065087
|
| MeSH Number(s) |
D27.505.519.562.061 D27.505.519.625.120.069 D27.505.696.577.120.069
|
| Concept/Terms |
Acetylcholine Release Inhibitors- Acetylcholine Release Inhibitors
- Inhibitors, Acetylcholine Release
- Acetylcholine Release Antagonists
- Antagonists, Acetylcholine Release
- Acetylcholine Release Blockers
- Blockers, Acetylcholine Release
- Release Blockers, Acetylcholine
|
Below are MeSH descriptors whose meaning is more general than "Acetylcholine Release Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Acetylcholine Release Inhibitors".
This graph shows the total number of publications written about "Acetylcholine Release Inhibitors" by people in this website by year, and whether "Acetylcholine Release Inhibitors" was a major or minor topic of these publications.
Below are the most recent publications written about "Acetylcholine Release Inhibitors" by people in Profiles.
-
Efficacy and safety of onabotulinumtoxinA for the treatment of overactive bladder in men and women: A pooled analysis. Neurourol Urodyn. 2024 Nov; 43(8):1765-1775.
-
Safety and Stability of Pulmonary Function in Patients with Decreased Respiratory Function Treated for Spasticity with OnabotulinumtoxinA. Toxins (Basel). 2020 10 19; 12(10).
-
Management of Anterocapitis and Anterocollis: A Novel Ultrasound Guided Approach Combined with Electromyography for Botulinum Toxin Injection of Longus Colli and Longus Capitis. Toxins (Basel). 2020 09 30; 12(10).
-
FDA Approvals and Consensus Guidelines for Botulinum Toxins in the Treatment of Dystonia. Toxins (Basel). 2020 05 17; 12(5).
-
Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in Adults: A Randomized Clinical Trial. JAMA Neurol. 2020 04 01; 77(4):461-469.
-
ASGE guideline on the management of achalasia. Gastrointest Endosc. 2020 02; 91(2):213-227.e6.
-
Botox injection into the lower esophageal sphincter induces hiatal paralysis and gastroesophageal reflux. Am J Physiol Gastrointest Liver Physiol. 2020 01 01; 318(1):G77-G83.
-
Role of botulinum neurotoxin-A in cerebral revascularization graft vasospasm prevention: current state of knowledge. Neurosurg Focus. 2019 02 01; 46(2):E13.
-
Botulinum toxin blocks mast cells and prevents rosacea like inflammation. J Dermatol Sci. 2019 Jan; 93(1):58-64.
-
Botulinum toxin for treatment of Raynaud phenomenon in CREST syndrome. Dermatol Online J. 2018 Dec 15; 24(12).